Price target
806.00RUSD+217.66+37.00%
The 21 analysts offering 1 year price forecasts for Regeneron Pharmaceuticals, Inc. have a max estimate of 958.00 and a min estimate of 535.00.
Analyst rating
Based on 28 analysts giving stock ratings to Regeneron Pharmaceuticals, Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
19
Buy
3
Hold
5
Sell
1
Strong sell
0
EPS
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
0.00
3.50
7.00
10.50
14.00
Reported
Estimate
Currency: USD
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Reported
11.59
11.86
9.55
11.56
12.46
12.07
8.22
—
—
—
—
Estimate
10.68
10.73
10.17
10.62
11.69
11.28
8.62
8.53
9.31
9.41
8.84
Surprise
+8.50%
+10.52%
−6.11%
+8.87%
+6.54%
+6.98%
−4.66%
—
—
—
—
Revenue
Forecast
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
0.00
1.00 B
2.00 B
3.00 B
4.00 B
Reported
Estimate
Currency: USD
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Reported
3.36 B
3.43 B
3.15 B
3.55 B
3.72 B
3.79 B
3.03 B
—
—
—
—
Estimate
3.23 B
3.29 B
3.23 B
3.38 B
3.67 B
3.74 B
3.25 B
3.29 B
3.44 B
3.60 B
3.27 B
Surprise
+4.04%
+4.25%
−2.49%
+4.83%
+1.25%
+1.25%
−6.74%
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
REGN EPS for the last quarter is 8.22 USD despite the estimation of 8.62 USD. In the next quarter EPS is expected to reach 8.53 USD. Track more of Regeneron Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Regeneron Pharmaceuticals, Inc. revenue is expected to reach 3.29 B USD. Check out Regeneron Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, REGN price target is 806.00 USD with a max estimate of 958.00 USD and a min estimate of 535.00 USD. Check if this forecast comes true in a year, meanwhile watch Regeneron Pharmaceuticals, Inc. stock price chart and keep track of the current situation with REGN news and stock market news.
We've gathered opinions of 28 analysts rating REGN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.